Impact and Prevalence of Depression and Anxiety in Rheumatoid Arthritis—A Cross-Sectional Study with Self-Reported Questionnaires

<b>Objective:</b> This study aims to screen for depression and anxiety in a real-life sample of rheumatoid arthritis (RA) patients and to observe whether RA phenotype characteristics and RA disease activity measures are associated with depression and anxiety. <b>Methods:</b> This cross-sectional study from a tertiary rheumatology hospital in Romania screened all patients with diagnosed RA that came for their one month disease follow-up for depression and anxiety using the Patient Health Questionnaire-9 (PHQ9) and Hospital Anxiety and Depression Scale (HADS), self-reported questionnaires. The follow-up captured the date of RA diagnosis, pharmacological treatment, clinical examination, blood sampling, and functional and radiographic assessment. The cut-off for positive screening of depression was a PHQ9 of 10 or more and a HADS-depression (D) of over 10, and the positive cut-off for anxiety was a HADS-anxiety (A) of over 10. <b>Results:</b> According to the medical histories, the prevalence of depression and anxiety in the 209 patients included was 10% and 8.1%, respectively, while the likely depression diagnosis according to PHQ was 34.4% and that according to HADS-D was 14.8%, while the likely anxiety diagnosis using the HADS-A was 32.5%. The subgroup of patients that positively screened for depression using the self-reported questionnaires PHQ9 and HADS-D had significantly higher DAS28, disease activity class, tender joint count, swollen joint count, patient global assessment, and functional stage, with some particularities regarding ESR and radiographic stage, which were higher just in the HADS-D of more than 10 subgroup, and glucocorticoid use, which was higher just in the PHQ9 over 10 subgroup. Regarding patients with a HADS-A of more than 10, they were more frequently women and had higher tender joint count and functional stage. <b>Conclusions:</b> Depression and anxiety are highly prevalent and underreported in the RA population and are associated with higher levels of pain, physical disability, and disease activity.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Medicine
Published
2025-03-04
DOI
https://doi.org/10.3390/jcm14051718
Citations
5
Primary Topic
Rheumatoid Arthritis Research and Therapies
Type
article
Field-Weighted Citation Impact
8.34

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Impact and Prevalence of Depression and Anxiety in Rheumatoid Arthritis—A Cross-Sectional Study with Self-Reported Questionnaires

C Popescu, Cătălina-Elena Ionescu, Cătălin Codreanu
5 citations
Journal of Clinical Medicine
Rheumatoid Arthritis Research and Therapies
8.34
article

Impact and Prevalence of Depression and Anxiety in Rheumatoid Arthritis—A Cross-Sectional Study with Self-Reported Questionnaires

C Popescu, Cătălina-Elena Ionescu, Cătălin Codreanu
article en
5 citations

Abstract

<b>Objective:</b> This study aims to screen for depression and anxiety in a real-life sample of rheumatoid arthritis (RA) patients and to observe whether RA phenotype characteristics and RA disease activity measures are associated with depression and anxiety. <b>Methods:</b> This cross-sectional study from a tertiary rheumatology hospital in Romania screened all patients with diagnosed RA that came for their one month disease follow-up for depression and anxiety using the Patient Health Questionnaire-9 (PHQ9) and Hospital Anxiety and Depression Scale (HADS), self-reported questionnaires. The follow-up captured the date of RA diagnosis, pharmacological treatment, clinical examination, blood sampling, and functional and radiographic assessment. The cut-off for positive screening of depression was a PHQ9 of 10 or more and a HADS-depression (D) of over 10, and the positive cut-off for anxiety was a HADS-anxiety (A) of over 10. <b>Results:</b> According to the medical histories, the prevalence of depression and anxiety in the 209 patients included was 10% and 8.1%, respectively, while the likely depression diagnosis according to PHQ was 34.4% and that according to HADS-D was 14.8%, while the likely anxiety diagnosis using the HADS-A was 32.5%. The subgroup of patients that positively screened for depression using the self-reported questionnaires PHQ9 and HADS-D had significantly higher DAS28, disease activity class, tender joint count, swollen joint count, patient global assessment, and functional stage, with some particularities regarding ESR and radiographic stage, which were higher just in the HADS-D of more than 10 subgroup, and glucocorticoid use, which was higher just in the PHQ9 over 10 subgroup. Regarding patients with a HADS-A of more than 10, they were more frequently women and had higher tender joint count and functional stage. <b>Conclusions:</b> Depression and anxiety are highly prevalent and underreported in the RA population and are associated with higher levels of pain, physical disability, and disease activity.

Journal of Clinical MedicineVol. 14(5)
Carol Davila University of Medicine and Pharmacy (RO)
Universitatea de Medicină şi Farmacie "Carol Davila" Bucureşti
Good health and well-being
Openalex Percentile: Top 3%
Rheumatoid Arthritis Research and Therapies
8.34
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.